| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP1409006A2 Methods of treating diabetes mellitus |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1409001A2 Mineral-protein preparations (mpp) and neuropathies in diabetes |
| 04/21/2004 | EP1409000A4 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1409000A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408992A2 Pharmaceutical composition for treating hypercholesterolaemia |
| 04/21/2004 | EP1408987A2 Tetracycline compounds having target therapeutic activities |
| 04/21/2004 | EP1408981A1 Methods for preventing antipsychotic-induced weight gain |
| 04/21/2004 | EP1408966A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 04/21/2004 | EP1408952A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 04/21/2004 | EP1408951A2 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 04/21/2004 | EP1408945A2 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 04/21/2004 | EP1408931A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408775A2 Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1159004A4 Novel redox clamping agents and uses thereof |
| 04/21/2004 | EP1149079B1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same |
| 04/21/2004 | EP1113790B1 Use of a cinnamic acid derivatives for the manufacture of a medicament for preventing or treating elevated blood lipid level-related diseases |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | EP0815218B1 Human vegf-specific antisense oligonucleotides |
| 04/21/2004 | CN1491232A Modified leptin with reduced immunogenicity |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491224A 5-[4-[2(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491197A Tropolone derivative |
| 04/21/2004 | CN1491114A Compositions for nasal administration of insulin |
| 04/21/2004 | CN1490333A Insulinotropic peptide and its use |
| 04/21/2004 | CN1490321A Effective parts of fructus sophorae flavone production and use thereof |
| 04/21/2004 | CN1490045A Sisal hemp extractive, preparing method and use thereof |
| 04/21/2004 | CN1490026A Bear gall lozenge and preparing method thereof |
| 04/21/2004 | CN1490025A Bear gall granular formulation and preparing method thereof |
| 04/21/2004 | CN1490024A Preparations of composition and fumigant for prosopalgia |
| 04/21/2004 | CN1490023A Therapy for self reduced regeneration of insulinic function |
| 04/21/2004 | CN1490019A Health cosmetic composition |
| 04/21/2004 | CN1490000A Hippophae rhamnoide flavone drops and preparation thereof |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146544C Pyrazoelcarboxylic acid derivatives, their preparation, pharmaceutical compositions containing |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146429C Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agent |
| 04/21/2004 | CN1146427C Solid oral dosage form comprising combination of metformin and glibenclamide |
| 04/21/2004 | CN1146415C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 04/20/2004 | US6723855 Chlorinating 5-methylisoxazole-4-carboxylic acid by reacting with chlorinating agent to form 5-methylisoxazole-4-carboxylic acid chloride, reacting with 4-trifluoromethylaniline in presence of alkali metal or alkaline earth metal bicarbonate |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723744 Indole carboxylic acids as thyroid receptor ligands |
| 04/20/2004 | US6723742 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723739 Glucopyranoside benzothiophenes |
| 04/20/2004 | US6723731 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity |
| 04/20/2004 | US6723721 CRF receptor antagonists and methods relating thereto |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723346 Flowable, non-dusty, and binder-free riboflavin granulates can be manufactured from a mixture of riboflavin crystals of modification b and c |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/15/2004 | WO2004031374A2 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 04/15/2004 | WO2004031203A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 04/15/2004 | WO2004031179A1 Indole-3-carboxamides as glucokinase (gk) activators |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004031175A2 N-substituted-2-oxodihydropyridine derivatives as npy antagonists |
| 04/15/2004 | WO2004031166A1 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof |
| 04/15/2004 | WO2004031162A1 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 04/15/2004 | WO2004031160A2 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 04/15/2004 | WO2004031159A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 04/15/2004 | WO2004031116A1 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them |
| 04/15/2004 | WO2004030700A1 Solid preparation |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030674A1 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004005550A3 Method of screening for antidiabetic agents |
| 04/15/2004 | WO2004005262A3 New neuropeptide y y5 receptor antagonists |
| 04/15/2004 | WO2004004774A3 Compositions comprising panthetine for the treatment of dyslipidemia |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003103704A3 L(2)44 dea, wunen-2, grapes, cg2221, cg1172, rutabaga, cg11940, facl involved in the regulation of energy homeostasis |
| 04/15/2004 | WO2003101988A3 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 04/15/2004 | WO2003092603B1 Composition and method for reducing post-prandial blood glucose |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003018823A8 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 04/15/2004 | WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002050090A8 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | WO2001092479A8 Method to determine the differentiation potential of a target cell |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040073956 Assay techniques based on growth stage dependent expression inc. elegans |
| 04/15/2004 | US20040073160 Intradermal delivery of substances |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072986 Ring opening polymerization of lactide, glycolide in presence of dextran sulfate in an extruder; sustained release; drug delivery |
| 04/15/2004 | US20040072895 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms |
| 04/15/2004 | US20040072894 Anticholesterol agents; compressed into tablets |
| 04/15/2004 | US20040072893 Antilipemic agents; anticholesterol agents |
| 04/15/2004 | US20040072892 Dipeptidyl aminopeptidase inhibitors; kidney and liver disorders; autoimmune diseases; antiarthritic agents; psoriasis; anticancer agents |
| 04/15/2004 | US20040072888 Administering pyrazoloanthrone compound |